Chha LogoLogo
California extends drug phase-in periods
Wednesday, July 27, 2005 - from the California Horse Racing Board

The California Horse Racing Board, in a recent memo, has advised licensed horsemen and veterinarians of an important change:

Changes to CHRB rule 1844 and 1845 dealing with permitted levels of nonsteroidal inflammatory medications and bleeder medications went into effect May 27, 2005, and horsemen and veterinarians were notified of these changes prior to the implementation date and were also advised that there would be a 60-day "phase-in" period penalties for violations of the new regulatory levels for flunixin and ketoprofen (CHRB 1844), so that veterinarians and trainers could adjust their administration protocols.

The phase-in period for penalties for violations of the new regulatory levels for flunixin and ketoprofen (CHRB 1844) that was scheduled to end July 26, 2005, has been extended and will now end September 27, 2005.

During the extended phase-in period, trainers will receive a warning when flunixin blood levels exceed 20 ng/ml, but are not greater than 500 ng/ml, or when ketoprofen blood levels exceed 10 ng/ml, but are not greater than 50 ng/ml.

Flunixin blood levels greater than 500 ng/ml or ketoprofen blood levels greater that 50 ng/ml will continue to be violations during this time period.